Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Abbott reports on new PAF antagonists

Dec. 13, 1996

Novel 5-HT4 receptor agonist claimed by Pharmacia & Upjohn

Dec. 13, 1996

NK1 antagonists described by Boehringer Ingelheim

Dec. 13, 1996

Roussel Uclaf reports new quinoline derivatives

Dec. 13, 1996

Therapeutically active cysteine proteinase inhibitors described by Synphar

Dec. 13, 1996

New antitumor agents from Kyowa Hakko

Dec. 12, 1996

Mitsubishi Chemical isolates novel antitumor agent from plant source

Dec. 12, 1996

Daiichi claims LTD4 antagonists for treating allergic diseases

Dec. 12, 1996

Italian researchers described novel anti-HIV compounds

Dec. 12, 1996

Novel dual-action compounds described by Abbott

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...